Trial Profile
Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 04 Dec 2015 New trial record